IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i24p16384-d995805.html
   My bibliography  Save this article

The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017–2019

Author

Listed:
  • Michal Seweryn

    (Associate of the Institute—European Observatory of Health Inequalities, Calisia University, 62-800 Kalisz, Poland
    EconMed Europe, 31-469 Krakow, Poland)

  • Tomasz Banas

    (Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków Branch, 31-115 Krakow, Poland)

  • Joanna Augustynska

    (EconMed Europe, 31-469 Krakow, Poland)

  • Ola Lorenc

    (EconMed Europe, 31-469 Krakow, Poland)

  • Justyna Kopel

    (EconMed Europe, 31-469 Krakow, Poland)

  • Elzbieta Pluta

    (Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków Branch, 31-115 Krakow, Poland)

  • Tomasz Skora

    (Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków Branch, 31-115 Krakow, Poland)

Abstract

Background: In Poland, breast cancer (BC) is the most frequently diagnosed cancer in women and the second most common cause of death after lung cancer. This disease has important economic implications for patients, public payers, and the whole Polish economy. This study aimed to estimate the total National Health Fund (NHF) expenditures on the diagnosis and treatment of patients with breast cancer. In addition, the costs of productivity losses were also calculated. Methods: Cost estimation was prepared using a top-down approach. Direct cost calculations were based on data reported by NHF for patients with the diagnosis of breast cancer. Medical care costs included the following components: screening program, oncological package, surgical treatment, hospitalization, drug program, chemotherapy, radiotherapy, and outpatient care. Indirect costs in the form of absenteeism costs were calculated based on data from Statistics Poland (gross domestic product, number of employees) and the Social Insurance Institution database (the number of sick leave days). Results: Total expenditures for BC including direct costs and indirect costs amounted to EUR 305,371, EUR 332,998, and EUR 344,649, respectively in 2017, 2018, and 2019. Total healthcare costs in 2019 were EUR 4114 lower than in 2018, which resulted from the reduction in expenditure on the drug program (decrease of EUR 13,527), despite the observed increase in all remaining resources. From direct costs, the highest expense was spent on the drug program (nearly 50% of total direct costs), but this expense dropped significantly in 2019. For the remaining parameters, the costs increased year by year, of which the most expensive were surgical treatment (15%), radiotherapy (12%), and the screening program (10%). BC generated over EUR 120 thousand of social costs in 2019 and compared to 2017, there was an increase in productivity loss by 26%. Conclusions: Our results from 2017–2019 demonstrated that total expenditure for BC in Poland increased from year to year. Breast cancer generated almost EUR 345 thousand expenses in 2019, which translates into a significant burden on the public payer’s budget and the society in Poland.

Suggested Citation

  • Michal Seweryn & Tomasz Banas & Joanna Augustynska & Ola Lorenc & Justyna Kopel & Elzbieta Pluta & Tomasz Skora, 2022. "The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017–2019," IJERPH, MDPI, vol. 19(24), pages 1-11, December.
  • Handle: RePEc:gam:jijerp:v:19:y:2022:i:24:p:16384-:d:995805
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/24/16384/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/19/24/16384/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:24:p:16384-:d:995805. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.